Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 8,750 shares at $4.42 ($39K) on 2026-10-05, disclosed to the SEC on 2026-10-05.
Open-market sale of $39k CLOV by CEO, Medicare Advantage. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLOV | SELL | 2026-09-15 | $44K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |
| CLOV | SELL | 2026-07-16 | $61K | — | Filing → |